stoxline Quote Chart Rank Option Currency Glossary
  
Miromatrix Medical Inc. (MIRO)
3.39  0.02 (0.59%)    12-12 16:00
Open: 3.38
High: 3.53
Volume: 631,561
  
Pre. Close: 3.37
Low: 3.36
Market Cap: 93(M)
Technical analysis
2024-01-12 4:52:35 PM
Short term     
Mid term     
Targets 6-month :  4.02 1-year :  4.12
Resists First :  3.44 Second :  3.52
Pivot price 3.38
Supports First :  3.29 Second :  2.74
MAs MA(5) :  3.39 MA(20) :  3.38
MA(100) :  2.09 MA(250) :  2
MACD MACD :  0.1 Signal :  0.1
%K %D K(14,3) :  33.3 D(3) :  33.3
RSI RSI(14): 75.3
52-week High :  3.73 Low :  0.9
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ MIRO ] has closed below upper band by 42.0%. Bollinger Bands are 93.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.4 - 3.41 3.41 - 3.43
Low: 3.34 - 3.37 3.37 - 3.38
Close: 3.36 - 3.39 3.39 - 3.42
Company Description

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

Headline News

Sun, 24 Mar 2024
Several Insiders Invested In Miromatrix Medical Flagging Positive News - Yahoo Movies Canada

Tue, 31 Oct 2023
United Therapeutics to buy Miromatrix Medical for around $91m - Medical Device Network

Mon, 30 Oct 2023
United Therapeutics buying Miromatrix for up to $140M - BioWorld Online

Mon, 30 Oct 2023
United Therapeutics to buy Miromatrix Medical - Washington - The Business Journals

Mon, 30 Oct 2023
Eden Prairie biotech company Miromatrix Medical selling for $91M - Star Tribune

Mon, 30 Oct 2023
United Therapeutics to Acquire Miromatrix Medical for $91M - HIT Consultant

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 27 (M)
Held by Insiders 1.961e+007 (%)
Held by Institutions 24.6 (%)
Shares Short 93 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -2.744e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -59 %
Return on Assets (ttm) 369 %
Return on Equity (ttm) -55.9 %
Qtrly Rev. Growth 958030 %
Gross Profit (p.s.) -980
Sales Per Share -11353
EBITDA (p.s.) 0
Qtrly Earnings Growth -1.2 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -24 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 0.05
Stock Dividends
Dividend 0
Forward Dividend 11660
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android